Clinical trial Recruiting at 1 site Phase 4 Interventional Ages 50 to 80

Knee Osteoarthritis: comparing saline, PRP, and PL injections

Official title: Comparison of Effectiveness Between Platelet Lysate and Platelet-rich Plasma on Knee Osteoarthritis: a Prospective, Randomized, Placebo-controlled Trial

Run by National Taiwan University Hospital · NCT03734900 · Data updated 2026-11-12

This study tests whether saline, platelet-rich plasma, or platelet lysate injections can relieve pain and improve function in people with knee OA.

Quick facts

PhasePhase 4
Study typeInterventional
Ages50 Years to 80 Years
SexAll
Enrollment150 (estimated)
SponsorNational Taiwan University Hospital
Academic / other
Locations1 site (Taipei)
StatusRecruiting
StartedMay 15, 2018
Main results expectedMay 14, 2027
Study endsMay 14, 2027
Registry record updatedSeptember 21, 2026
Trial IDNCT03734900 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 50–80 with radiographic knee OA (Kellgren-Lawrence grade 1–3) and significant knee pain.

Probably not a fit

Patients with advanced deformity, instability, or contraindications to injections may not benefit from these treatments.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a randomized, placebo-controlled phase 4 trial enrolling adults with grade 1–3 knee OA. Participants are assigned to receive saline, PRP, or PL injections into the knee and are followed to assess outcomes. The trial aims to determine the relative effectiveness and safety of autologous platelet products compared with placebo. Platelet lysate is expected to reduce inflammation and pain with potentially fewer inflammatory responses than PRP. The lead site is National Taiwan University Hospital.

Why it matters

Potential benefit: If successful, patients may experience better pain control and function with a treatment that could reduce medical costs and delay surgery.

How similar studies have gone: Previous studies with platelet products show promise for knee OA, but results vary and this trial adds a direct comparison to placebo.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* 50 to 80 years old
* Study Subjects must be willing to sign Informed Consent to participate in the study
* In the past month, at least seven consecutive days in the squat, standing, walking or going up and down the stairs, the most serious degree of visual analogy of the knee pain (Visual Analogue Scale) is greater than or equal to 40 (the most pain is 100, not painful is 0)
* Morning joint stiffness is less than 30 minutes
* X-ray:Grade 1-3 radiographic OA as defined by the K-L classification

Exclusion Criteria:

* Knee instability
* The knee joint is obviously deformed (\> 5 degree valgus or varus deviation on X-ray)
* Clinical diagnosed as Pes tendinitis, Chondromalacia
* Taking NSAIDs or steroids (including oral and injection) within one week
* Using anticoagulant drugs for a long time
* Platelet count is less than 150,000 / UL, or coagulation disorders, prothrombin time (PT value) is less than 11 seconds or greater than 16 seconds
* Leukemia, sepsis, platelet dysfunction or other blood related diseases
* tumors, infections or the trauma before the same site
* Pregnancy

Where it's running

  • National Taiwan University Hospital
    Taipei, Taiwan
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • Medial knee osteoarthritis: inside vs outside corticosteroid injection

    This study tests whether injecting a steroid inside the knee joint leads to different pain results than injecting it on the outside of the knee in people with medial knee osteoarthritis.

    Recruiting at 5 sites University of Chicago · Bolingbrook, Illinois and 4 other locations · NCT07804446

  • Platelet-rich plasma added to hyaluronic acid for knee osteoarthritis

    This study tests whether a single injection of hyaluronic acid plus autologous platelet-rich plasma helps reduce knee OA symptoms more than hyaluronic acid alone in adults with moderate knee OA.

    Recruiting Implai Sp z o.o · Warsaw, Masovian Voivodeship · NCT07785401

  • Hyaluronic Acid Plus PRP Injection for Knee Osteoarthritis

    This study tests whether a single HA injection combined with a patient’s own PRP is better at easing knee OA pain than HA alone.

    Recruiting Implai Sp z o.o · Chełm, Lublin Voivodeship · NCT07784907

  • Long-acting local pain medicine after knee replacement

    This study tests whether a new extended-release pain medicine (Zynrelef) given around the knee during total knee replacement can reduce pain after surgery better or as well as standard injections or nerve blocks.

    Recruiting Phase 4 Henry Ford Health System · Grosse Pointe Farms, Michigan · NCT07775248

  • Choose to Move Replacement Ready for OA patients waiting for hip or knee replacement

    This program tests a tailored, online version of a 3-month activity and social-connection plan for older adults with hip or knee osteoarthritis who are waiting for joint replacement surgery to see if it improves physical activity and health while they wait.

    Recruiting University of British Columbia · Vancouver, British Columbia · NCT07696650

  • Modular powered knee braces to help move better and reduce knee pain

    A device with partial motor support is being tested in adults with knee OA to see if it can ease pain and reduce effort during daily activities.

    Recruiting University of Michigan · Ann Arbor, Michigan · NCT07673328

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.